What are the Harrison guidelines for managing Diabetic Ketoacidosis (DKA)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 20, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Harrison Guidelines for Managing Diabetic Ketoacidosis (DKA)

The management of DKA requires immediate fluid resuscitation with isotonic saline (15-20 ml/kg/hour for the first hour), followed by insulin therapy (0.1 units/kg/hour continuous IV infusion without initial bolus), electrolyte replacement (especially potassium when <5.5 mEq/L), and treatment of underlying causes, with close monitoring of vital signs, neurological status, and laboratory parameters. 1

Diagnostic Criteria for DKA

DKA is diagnosed based on the following criteria as defined by the American Diabetes Association:

  • Blood glucose >250 mg/dL
  • Arterial pH <7.3
  • Bicarbonate <15 mEq/L
  • Moderate ketonemia or ketonuria 1

Severity Classification

Parameter Mild Moderate Severe
Arterial pH 7.25-7.30 7.00-7.24 <7.00
Bicarbonate (mEq/L) 15-18 10-14 <10
Mental Status Alert Alert/drowsy Stupor/coma

Treatment Algorithm

1. Fluid Therapy

  • Initial fluid resuscitation: Isotonic saline at 15-20 ml/kg/hour for the first hour
  • Subsequent fluid therapy: 0.45% saline at 4-14 ml/kg/hour based on corrected sodium levels
  • Balanced crystalloid solutions preferred over normal saline for maintenance fluid therapy 1
  • Calculate corrected sodium using: Measured sodium + 1.6 × [(glucose mg/dl - 100)/100] 1

2. Insulin Therapy

  • Start continuous IV insulin infusion at 0.1 units/kg/hour without an initial bolus
  • Target glucose reduction rate: 50-70 mg/dL/hour
  • For patients with chronic kidney disease and heart failure: Reduced rate of 0.05 units/kg/hour 1
  • Alternative for uncomplicated DKA: Subcutaneous rapid-acting insulin analogs in emergency departments 1

3. Electrolyte Management

  • Potassium: Begin replacement when serum K+ <5.5 mEq/L
    • Add 20-30 mEq/L potassium to IV fluids (2/3 KCl and 1/3 KPO₄) 1
  • Phosphate: Include in replacement as KPO₄, especially with severe hypophosphatemia 1
  • Bicarbonate: Generally contraindicated 2

4. Monitoring

  • Hourly monitoring:
    • Vital signs
    • Neurological status
    • Blood glucose
    • Fluid input/output 1
  • Every 2-4 hours:
    • Electrolytes
    • BUN
    • Creatinine
    • Venous pH 1

Resolution Criteria

DKA is considered resolved when:

  • Glucose <200 mg/dL
  • Serum bicarbonate ≥18 mEq/L
  • Venous pH >7.3 1

Complications and Prevention

Cerebral Edema

  • Rare but potentially fatal complication (0.7-1.0% in children)
  • Prevention strategies:
    • Avoid too rapid correction of serum osmolality (not exceeding 3 mOsm/kg/h)
    • Limit initial vascular expansion to 50 ml/kg in the first 4 hours in pediatric patients 1
    • Administer insulin 1-2 hours after starting fluid therapy 2

Other Complications

  • Hypoglycemia
  • Hypokalemia
  • Fluid overload 1

Patient Education and Follow-up

  • Identify and treat underlying causes (infection, missed insulin, new diagnosis)
  • Before discharge, provide education on:
    • Diabetes self-management
    • Blood glucose monitoring
    • When to seek medical attention
    • Sick-day management
    • Proper medication administration 1
  • Schedule follow-up appointment prior to discharge 1

Special Considerations

  • Pediatric patients require careful attention to fluid management to prevent cerebral edema 2
  • Sodium-glucose cotransporter-2 (SGLT2) inhibitors increase risk of euglycemic DKA 3
  • Mixed presentations of DKA and Hyperglycemic Hyperosmolar Syndrome (HHS) require tailored management 4

References

Guideline

Management of Hemoconcentration and Electrolyte Abnormalities

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

The management of diabetic ketoacidosis in children.

Diabetes therapy : research, treatment and education of diabetes and related disorders, 2010

Research

Diabetic Ketoacidosis: Evaluation and Treatment.

American family physician, 2024

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.